EMA - International Pharmaceutical Industry

Volume 14 issue 3

The Transformational Potential of Prioritising Data Today

Covid has spurred regulators towards a more agile and innovation-supporting future, paving the way for new opportunities for all. If life sciences companies embrace ...

10 October 2022 Volume 14 issue 3 Affairs | agile

Continue Reading →

News

EMA fast-tracks Marinus Pharma’s rare epilepsy treatment

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved Marinus Pharmaceuticals’ request for accelerated assessment ...

1 September 2021 News CDD | CDKL5 deficiency disorder

Continue Reading →

News

Brexit rare disease warning from Cambridge dad hoping to cure sons

A Cambridge dad hoping to find a cure for a devastating condition which affects his two boys has warned of the potential consequences of Brexit on rare disease resea...

3 April 2018 News alkaptonuria | Brexit

Continue Reading →

News

EMA to review cemiplimab as a potential treatment for advanced cutaneous squamous cell carcinoma

The European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for cemiplimab for the treatment of patients with metastati...

3 April 2018 News cemiplimab | CSCC

Continue Reading →

News

EMA to review sotagliflozin as potential treatment for type 1 diabetes

The European Medicines Agency (EMA) has accepted for review Sanofi's regulatory submission for sotagliflozin. If approved, the oral treatment would be used as an add...

29 March 2018 News Agency | diabetes

Continue Reading →

News

Copley Scientific to showcase new TPK™ 2100 Critical Flow Controller for dry powder inhaler testing at DDL2017

Copley Scientific, the world’s leading manufacturer of inhaler test equipment, will be presenting its new 3rd generation Critical Flow Controller – the TPK™ 2100 – f...

28 November 2017 News drug delivery | dry

Continue Reading →

News

Focus should be on public health and patient safety after EMA relocation decision, says Brexit Health Alliance

Responding to the announcement about the new location of the European Medicines Agency (EMA), Niall Dickson, co-chair of the Brexit Health Alliance, said: “The ...

21 November 2017 News Brexit | EMA

Continue Reading →